• Tolga B Mesen, Jennifer E Mersereau, Jennifer B Kane, and Anne Z Steiner.
• Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina. Electronic address: tolga_mesen@med.unc.edu.
• Fertil. Steril. 2015 Jun 1; 103 (6): 1551-6.e1-4.

ObjectiveTo estimate the optimal age to pursue elective oocyte cryopreservation.DesignA decision-tree model was constructed to determine the success and cost-effectiveness of oocyte preservation versus no action when considered at ages 25-40 years, assuming an attempt at procreation 3, 5, or 7 years after initial decision.SettingNot applicable.Patient(S)Hypothetical patients 25-40 years old presenting to discuss elective oocyte cryopreservation.Intervention(S)Decision to cryopreserve oocytes from age 25 years to age 40 years versus taking no action.Main Outcome And Measure(S)Probability of live birth after initial decision whether or not to cryopreserve oocytes.Result(S)Oocyte cryopreservation provided the greatest improvement in probability of live birth compared with no action (51.6% vs. 21.9%) when performed at age 37 years. The highest probability of live birth was seen when oocyte cryopreservation was performed at ages <34 years (>74%), although little benefit over no action was seen at ages 25-30 years (2.6%-7.1% increase). Oocyte cryopreservation was most cost-effective at age 37 years, at $28,759 per each additional live birth in the oocyte cryopreservation group. When the probability of marriage was included, oocyte cryopreservation resulted in little improvement in live birth rates.Conclusion(S)Oocyte cryopreservation can be of great benefit to specific women and has the highest chance of success when performed at an earlier age. At age 37 years, oocyte cryopreservation has the largest benefit over no action and is most cost-effective.Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

40 keywords...

hide…